CLU and early-onset autosomal dominant Alzheimer disease: Moreover, a recent study has shown that increased plasma clusterin concentrations are significantly related to the severity and progression of Alzheimer's disease [13], suggesting that plasma clusterin as a potential peripheral biomarker of Alzheimer's disease.